Video Experimental Relacionado
Updated: Aug 14, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Los antagonistas excitatorios de aminoácidos proporcionan un enfoque terapéutico para los trastornos neurológicos
Lancet (London, England)
|July 20, 1985
Resumen
La excesiva excitación del neurotransmisor puede matar a las neuronas, contribuyendo a varios trastornos neurológicos. La antagonización de esta excitotoxicidad presenta una estrategia terapéutica prometedora para las enfermedades neurodegenerativas.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Neurología Neurología.
- Farmacología Farmacología.
Sus antecedentes:
- La actividad excesiva de los neurotransmisores, conocida como excitotoxicidad, es una causa significativa de muerte neuronal.
- Este proceso está implicado en la patogénesis de numerosas afecciones neurológicas, incluyendo accidente cerebrovascular, epilepsia y enfermedad de Alzheimer.
Objetivo del estudio:
- Explorar el papel de la excitotoxicidad en la pérdida neuronal en varios trastornos neurológicos.
- Investigar el potencial de antagonizar la neurotransmisión excitatoria como una intervención terapéutica.
Principales métodos:
- Revisión de la literatura existente sobre la excitotoxicidad y sus mecanismos moleculares.
- Análisis de estudios que investigan compuestos que modulan la neurotransmisión excitatoria.
Principales resultados:
- La excitotoxicidad es una vía común que conduce al daño neuronal en condiciones como accidente cerebrovascular, parálisis cerebral, epilepsia y trastornos degenerativos crónicos como el Alzheimer y la enfermedad de Huntington.
- Los hallazgos destacan el potencial de los agentes terapéuticos dirigidos a la neurotransmisión excitatoria.
Conclusiones:
- Dirigirse a las vías excitotóxicas ofrece una nueva vía terapéutica para controlar la pérdida neuronal en una variedad de afecciones neurológicas debilitantes.
- Se necesita más investigación sobre antagonistas específicos para desarrollar tratamientos efectivos para estos trastornos.
Videos de Conceptos Relacionados
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...